Tucatinib
Tucatinib | |
---|---|
Term | Tucatinib |
Short definition | tucatinib - (pronounced) (too-KA-tih-nib) drug used with trastuzumab and capecitabine to treat adults with HER2-positive breast cancer that is advanced and cannot be surgically removed or has spread to other parts of the body, including the brain. It is used in patients whose cancer has already been treated with at least one other anti-HER2 therapy. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
tucatinib - (pronounced) (too-KA-tih-nib) drug used with trastuzumab and capecitabine to treat adults with HER2-positive breast cancer that is advanced and cannot be surgically removed or has spread to other parts of the body, including the brain. It is used in patients whose cancer has already been treated with at least one other anti-HER2 therapy. It is also being studied in the treatment of other types of cancer. Tucatinib blocks a protein called HER2, which can help prevent cancer cells from growing and kill them. It's a type of tyrosine kinase inhibitor. Also called Tukysa
External links
- Medical encyclopedia article on Tucatinib
- Wikipedia's article - Tucatinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski